-
Generative AI offers founders an opportunity to completely reinvent workflows — and will spawn a new cohort of fully AI-native companies.
-
100% of stock trades used to be made by humans. Today, 80% are made by computer algorithms. AI is about to bring a similar revolution to healthcare. Over the next few decades, at least half of the $4.3 trillion dollar American healthcare industry will be AI-driven.
-
Each new modality needs to find its platform-disease fit—the diseases it is uniquely suited for. But finding fit has increasingly turned into a fight; many have crowded into the same indications. With an expanding arsenal to treat disease, how will patients, clinicians, and the market determine what tool to use?
-
We aim to demystify the “B2FI” (or “business to financial institution”) for fintech companies, with lessons from those who have experienced it.
-
At the end of the day, even the best AI models will fail if they don’t figure out a way to achieve broad distribution and profitable monetization, so it’s important to understand the psyche of the buyers and decision makers who will determine the fate of your products.
-
How cross-border infrastructure, instant payments, and open banking advances are creating a more integrated, financially inclusive world.
-
When a platform shift reshapes the technology landscape, who wins? We unpack the market dynamics between startups and incumbents from the SaaS and cloud era that are likely to play out in the AI era.
-
Many digital-first companies have been propelled by generative AI. However, selling these digital products globally is not a straightforward undertaking. Here's how to simplify the cross-border selling experience, get in front of the right customers, and build long-term value.
-
We believe the largest opportunity long-term is in leveraging AI to change not just how we create games, but the nature of the games themselves.